DUCEST Neurostimulator V

The DUCEST Neurostimulator V opens up new minimally invasive possibilities for the additive therapy of peripheral arterial occlusive disease (PAOD) as well as chronic pain. Through intermittent stimulation using a stimulation needle applied to the ear, DUCEST neurostimulation therapy involves the brainstem in the treatment. The vegetative nervous system is modulated and positively influenced via an afferent nerve plexus located at the triangular fossa, which leads via C2 and C3 to the nucleus tractus solitarii in the brainstem. The results are higher parasympathetic activity, better blood circulation in the capillaries, and an increase in transcutaneous oxygen partial pressure.

When the stimulation needle is connected to the DUCEST Neurostimulator V, the device is activated and begins to stimulate at 1 Hertz. After 40 minutes of stimulation, a 20-minute pause follows. The alternation of both phases is automatically continued for 21 days. The device is fixed to the shoulder and the current strength is adjusted so that it is barely perceptible to patients. In later therapy phases, the impulses are often no longer perceived subjectively.

Therapy with the DUCEST Neurostimulator V increases the chances for PAOD patients to achieve longer walking distances and reduced pain perception. Ducest neurostimulation therapy is a new option for supplementary and patient-friendly treatment of PAOD and other chronic pain conditions.